ZORATTI, MARIO
ZORATTI, MARIO
Istituto di Neuroscienze - IN -
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges
2022 Parrasia, S; Szabo, I; Zoratti, M; Biasutto, L
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo
2022 Bachmann M.; Rossa A.; Varanita T.; Fioretti B.; Biasutto L.; Milenkovic S.; Checchetto V.; Peruzzo R.; Ahmad S.A.; Patel S.H.; Lukowski R.; Edwards M.J.; Ceccarelli M.; Gulbins E.; Zoratti M.; Mattarei A.; Szabo I.
An angiopep2-paptp construct overcomes the blood-brain barrier. New perspectives against brain tumors
2021 Parrasia, Sofia; Rossa, Andrea; Varanita, Tatiana; Checchetto, Vanessa; De Lorenzi, Riccardo; Zoratti, Mario; Paradisi, Cristina; Ruzza, Paolo; Mattarei, Andrea; Szabò, Ildikò; Biasutto, Lucia
Multiple Mechanisms Converging on Transcription Factor EB Activation by the Natural Phenol Pterostilbene
2021 La Spina, Martina; Azzolini, Michele; Salmaso, Andrea; Parrasia, Sofia; Galletta, Eva; Schiavone, Marco; Chrisam, Martina; Mattarei, Andrea; DI BENEDETTO, Giulietta; Ballabio, Andrea; Tiso, ; Zoratti, Mario; Biasutto, Lucia
Synthesis and cellular effects of a mitochondria-targeted inhibitor of the two-pore potassium channel TASK-3
2021 Bachmann, Magdalena; Rossa, Andrea; Antoniazzi, Giuseppe; Biasutto, Lucia; Carrer, Andrea; Campagnaro, Monica; Leanza, Luigi; Gonczi, Monika; Csernoch, Laszlo; Paradisi, Cristina; Mattarei, Andrea; Zoratti, Mario; Szabo, Ildiko
Targeting mitochondrial ion channels for cancer therapy
2021 Szabo, Ildiko; Zoratti, Mario; Biasutto, Lucia
Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
2021 Parrasia, Sofia; Zoratti, Mario; Szabò, Ildikò; Biasutto, Lucia
Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family
2020 Peruzzo R.; Mattarei A.; Azzolini M.; BeckerFlegler K.A.; Romio M.; Rigoni G.; Carrer A.; Biasutto L.; Parrasia S.; Kadow S.; Manago A.; Urbani A.; Rossa A.; Semenzato G.; Soriano M.E.; Trentin L.; Ahmad S.; Edwards M.; Gulbins E.; Paradisi C.; Zoratti M.; Leanza L.; Szabo I.
Impaired Mitochondrial ATP Production Downregulates Wnt Signaling via ER Stress Induction
2019 Costa R.; Peruzzo R.; Bachmann M.; Monta G.D.; Vicario M.; Santinon G.; Mattarei A.; Moro E.; QuintanaCabrera R.; Scorrano L.; Zeviani M.; Vallese F.; Zoratti M.; Paradisi C.; Argenton F.; Brini M.; Cali T.; Dupont S.; Szabo I.; Leanza L.
Inhibition of PI-3-K and AKT amplifies Kv1.3 Inhibitor-induced death of human T leukemia cells
2019 Bergermann, T; Born, L; Ferguson, F; Latkovic, P; Scheul, A; Sonnenschein, N; Leanza, L; Keitsch, S; Sehl, C; Wilker, B; Edwards, Mj; Zoratti, M; Paradisi, C; Kohnena, M; Szabo, I; Becker, Ka; Carpinteiro, A
Pharmacological modulation of mitochondrial ion channels
2019 Leanza L.; Checchetto V.; Biasutto L.; Rossa A.; Costa R.; Bachmann M.; Zoratti M.; Szabo I.
Pterostilbene Improves Cognitive Performance in Aged Rats: An in Vivo Study
2019 La Spina, M.; Sansevero, G.; Biasutto, L.; Zoratti, M.; Peruzzo, R.; Berardi, N.; Sale, A.; Azzolini, M.
Small-molecule modulators of mitochondrial channels as chemotherapeutic agents
2019 Parrasia, S; Mattarei, A; Furlan, A; Zoratti, M; Biasutto, L
Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds
2019 Biasutto, L; Mattarei, A; La Spina, M; Azzolini, M; Parrasia, S; Szabo, I; Zoratti, M
Novel mitochondria-targeted furocoumarin derivatives as possible anti-cancer agents
2018 Mattarei, A; Romio, M; Manago, A; Zoratti, M; Paradisi, C; Szabo, I; Leanza, L; Biasutto, L
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo
2017 Leanza L.; Romio M.; Becker K.A.; Azzolini M.; Trentin L.; Manago A.; Venturini E.; Zaccagnino A.; Mattarei A.; Carraretto L.; Urbani A.; Kadow S.; Biasutto L.; Martini V.; Severin F.; Peruzzo R.; Trimarco V.; Egberts J.H.; Hauser C.; Visentin A.; Semenzato G.; Kalthoff H.; Zoratti M.; Gulbins E.; Paradisi C.; Szabo I.
LETM1-mediated K+and Na+homeostasis regulates mitochondrial Ca2+efflux
2017 Austin S.; Tavakoli M.; Pfeiffer C.; Seifert J.; Mattarei A.; De Stefani D.; Zoratti M.; Nowikovsky K.
Mitochondrial genetic haplogroups and depressive symptoms: A large study among people in North America
2017 Veronese, N; Stubbs, B; Solmi, M; Vaona, A; Demurtas, J; Carvalho, Af; Koyanagi, A; Thompson, T; Zoratti, M; Maggi, S
New natural amino acid-bearing prodrugs boost pterostilbene's oral pharmacokinetic and distribution profile
2017 Azzolini, M; Mattarei, A; La Spina, M; Fanin, M; Chiodarelli, G; Romio, M; Zoratti, M; Paradisi, C; Biasutto, L
Novel lipid-mimetic prodrugs delivering active compounds to adipose tissue
2017 Mattarei, A; Rossa, A; Bombardelli, V; Azzolini, M; La Spina, M; Paradisi, C; Zoratti, M; Biasutto, L
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges | 1-gen-2022 | Parrasia, S; Szabo, I; Zoratti, M; Biasutto, L | |
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo | 1-gen-2022 | Bachmann M.; Rossa A.; Varanita T.; Fioretti B.; Biasutto L.; Milenkovic S.; Checchetto V.; Peruzzo R.; Ahmad S.A.; Patel S.H.; Lukowski R.; Edwards M.J.; Ceccarelli M.; Gulbins E.; Zoratti M.; Mattarei A.; Szabo I. | |
An angiopep2-paptp construct overcomes the blood-brain barrier. New perspectives against brain tumors | 1-gen-2021 | Parrasia, Sofia; Rossa, Andrea; Varanita, Tatiana; Checchetto, Vanessa; De Lorenzi, Riccardo; Zoratti, Mario; Paradisi, Cristina; Ruzza, Paolo; Mattarei, Andrea; Szabò, Ildikò; Biasutto, Lucia | |
Multiple Mechanisms Converging on Transcription Factor EB Activation by the Natural Phenol Pterostilbene | 1-gen-2021 | La Spina, Martina; Azzolini, Michele; Salmaso, Andrea; Parrasia, Sofia; Galletta, Eva; Schiavone, Marco; Chrisam, Martina; Mattarei, Andrea; DI BENEDETTO, Giulietta; Ballabio, Andrea; Tiso, ; Zoratti, Mario; Biasutto, Lucia | |
Synthesis and cellular effects of a mitochondria-targeted inhibitor of the two-pore potassium channel TASK-3 | 1-gen-2021 | Bachmann, Magdalena; Rossa, Andrea; Antoniazzi, Giuseppe; Biasutto, Lucia; Carrer, Andrea; Campagnaro, Monica; Leanza, Luigi; Gonczi, Monika; Csernoch, Laszlo; Paradisi, Cristina; Mattarei, Andrea; Zoratti, Mario; Szabo, Ildiko | |
Targeting mitochondrial ion channels for cancer therapy | 1-gen-2021 | Szabo, Ildiko; Zoratti, Mario; Biasutto, Lucia | |
Targeting Pancreatic Ductal Adenocarcinoma (PDAC) | 1-gen-2021 | Parrasia, Sofia; Zoratti, Mario; Szabò, Ildikò; Biasutto, Lucia | |
Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family | 1-gen-2020 | Peruzzo R.; Mattarei A.; Azzolini M.; BeckerFlegler K.A.; Romio M.; Rigoni G.; Carrer A.; Biasutto L.; Parrasia S.; Kadow S.; Manago A.; Urbani A.; Rossa A.; Semenzato G.; Soriano M.E.; Trentin L.; Ahmad S.; Edwards M.; Gulbins E.; Paradisi C.; Zoratti M.; Leanza L.; Szabo I. | |
Impaired Mitochondrial ATP Production Downregulates Wnt Signaling via ER Stress Induction | 1-gen-2019 | Costa R.; Peruzzo R.; Bachmann M.; Monta G.D.; Vicario M.; Santinon G.; Mattarei A.; Moro E.; QuintanaCabrera R.; Scorrano L.; Zeviani M.; Vallese F.; Zoratti M.; Paradisi C.; Argenton F.; Brini M.; Cali T.; Dupont S.; Szabo I.; Leanza L. | |
Inhibition of PI-3-K and AKT amplifies Kv1.3 Inhibitor-induced death of human T leukemia cells | 1-gen-2019 | Bergermann, T; Born, L; Ferguson, F; Latkovic, P; Scheul, A; Sonnenschein, N; Leanza, L; Keitsch, S; Sehl, C; Wilker, B; Edwards, Mj; Zoratti, M; Paradisi, C; Kohnena, M; Szabo, I; Becker, Ka; Carpinteiro, A | |
Pharmacological modulation of mitochondrial ion channels | 1-gen-2019 | Leanza L.; Checchetto V.; Biasutto L.; Rossa A.; Costa R.; Bachmann M.; Zoratti M.; Szabo I. | |
Pterostilbene Improves Cognitive Performance in Aged Rats: An in Vivo Study | 1-gen-2019 | La Spina, M.; Sansevero, G.; Biasutto, L.; Zoratti, M.; Peruzzo, R.; Berardi, N.; Sale, A.; Azzolini, M. | |
Small-molecule modulators of mitochondrial channels as chemotherapeutic agents | 1-gen-2019 | Parrasia, S; Mattarei, A; Furlan, A; Zoratti, M; Biasutto, L | |
Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds | 1-gen-2019 | Biasutto, L; Mattarei, A; La Spina, M; Azzolini, M; Parrasia, S; Szabo, I; Zoratti, M | |
Novel mitochondria-targeted furocoumarin derivatives as possible anti-cancer agents | 1-gen-2018 | Mattarei, A; Romio, M; Manago, A; Zoratti, M; Paradisi, C; Szabo, I; Leanza, L; Biasutto, L | |
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo | 1-gen-2017 | Leanza L.; Romio M.; Becker K.A.; Azzolini M.; Trentin L.; Manago A.; Venturini E.; Zaccagnino A.; Mattarei A.; Carraretto L.; Urbani A.; Kadow S.; Biasutto L.; Martini V.; Severin F.; Peruzzo R.; Trimarco V.; Egberts J.H.; Hauser C.; Visentin A.; Semenzato G.; Kalthoff H.; Zoratti M.; Gulbins E.; Paradisi C.; Szabo I. | |
LETM1-mediated K+and Na+homeostasis regulates mitochondrial Ca2+efflux | 1-gen-2017 | Austin S.; Tavakoli M.; Pfeiffer C.; Seifert J.; Mattarei A.; De Stefani D.; Zoratti M.; Nowikovsky K. | |
Mitochondrial genetic haplogroups and depressive symptoms: A large study among people in North America | 1-gen-2017 | Veronese, N; Stubbs, B; Solmi, M; Vaona, A; Demurtas, J; Carvalho, Af; Koyanagi, A; Thompson, T; Zoratti, M; Maggi, S | |
New natural amino acid-bearing prodrugs boost pterostilbene's oral pharmacokinetic and distribution profile | 1-gen-2017 | Azzolini, M; Mattarei, A; La Spina, M; Fanin, M; Chiodarelli, G; Romio, M; Zoratti, M; Paradisi, C; Biasutto, L | |
Novel lipid-mimetic prodrugs delivering active compounds to adipose tissue | 1-gen-2017 | Mattarei, A; Rossa, A; Bombardelli, V; Azzolini, M; La Spina, M; Paradisi, C; Zoratti, M; Biasutto, L |